Storylines
Track narrative continuity separately from authoritative updates and early community radar.
How to use: choose continuity or verified updates → open one card → inspect its current sources and evidence status.
Sorted by momentum. Use the chevron to expand a card. Use the action button for the full drawer.
No investment advice. Research signals and sources only. EarlyNarratives provides informational signals derived from public sources. It does not provide financial, legal, or tax advice.
Editorial weekly synthesis. Use the tracker below for continuity between issues.
No weekly storylines yet.
Track what changed, what held, and what to watch next across recent runs. Sorted by momentum.
EMA publishes materials for October 2026 CHMP meeting
The European Medicines Agency has published an agenda, annex and event listing for the Committee for Medicinal Products for Human Use meeting scheduled for 12–15 October 2026. The materials do not report any resulting opinions or approvals.
Details
- The meeting is scheduled for 12–15 October 2026.
- EMA has published the agenda, annex and event listing.
Contrasting signals emerge for two drug-development programs
Reports on two separate drug-development programs provide contrasting signals: potential filings for a Bristol Myers Squibb idiopathic pulmonary fibrosis drug and data that undercut the potential of MSD's eye drug remigromig.
Details
- Both reports were published in the same news cycle.
- Together they provide a snapshot of current development signals for two programs.
Free gives current signals and storylines with source links. Pro adds archive, alerts, watchlists, exports, and workflow tools. Business adds Feed API and team usage.